Getting the Most out of (18)F-FDG PET Scans: The Predictive Value of (18)F-FDG PET–Derived Blood Flow Estimates for Breast Cancer

Por Doot, Robert K.
Publicado no J Nucl Med (2016)

Practical Methods for Estimating Metabolic Flux (Ki) to Assess Response to Therapy via Static PET Scans

Por Doot, Robert K.
Publicado no J Nucl Med (2019)

Role of PET quantitation in the monitoring of cancer response to treatment: Review of approaches and human clinical trials

Por Doot, Robert K., McDonald, Elizabeth S., Mankoff, David A.
Publicado em 2014

Design considerations for using PET as a response measure in single- and multi-center clinical trials

Por Doot, Robert K., Kurland, Brenda F., Kinahan, Paul E., Mankoff, David A.
Publicado em 2011

Selectivity of probes for PET imaging of dopamine D3 receptors

Por Doot, Robert K., Dubroff, Jacob G., Labban, Kyle J., Mach, Robert H.
Publicado no Neurosci Lett (2018)

Multicenter trials using FDG PET to predict chemotherapy response : Effects of differential measurement error and bias on power calculations for unselected and enrichment designs

Por Kurland, Brenda F, Doot, Robert K, Linden, Hannah M, Mankoff, David A, Kinahan, Paul E
Publicado em 2013

Variability in PET quantitation within a multicenter consortium

Por Fahey, Frederic H., Kinahan, Paul E., Doot, Robert K., Kocak, Mehmet, Thurston, Harold, Poussaint, Tina Young
Publicado em 2010

Biases in Multicenter Longitudinal PET Standardized Uptake Value Measurements

Por Doot, Robert K, Pierce, Larry A, Byrd, Darrin, Elston, Brian, Allberg, Keith C, Kinahan, Paul E
Publicado em 2014

A Virtual Clinical Trial of FDG-PET Imaging of Breast Cancer: Effect of Variability on Response Assessment

Por Harrison, Robert L, Elston, Brian F, Doot, Robert K, Lewellen, Thomas K, Mankoff, David A, Kinahan, Paul E
Publicado em 2014

Kinetic Analysis of (18)F-Fluoride PET Images of Breast Cancer Bone Metastases

Por Doot, Robert K., Muzi, Mark, Peterson, Lanell M., Schubert, Erin K., Gralow, Julie R., Specht, Jennifer M., Mankoff, David A.
Publicado em 2010

QIN. Early experiences in establishing a regional quantitative imaging network for PET/CT clinical trials

Por Doot, Robert K., Thompson, Tove, Greer, Benjamin E., Allberg, Keith C., Linden, Hannah M., Mankoff, David A., Kinahan, Paul E.
Publicado em 2012

Quantifying and Reducing the Effect of Calibration Error on Variability of PET/CT Standardized Uptake Value Measurements

Por Lockhart, Catherine M., MacDonald, Lawrence R., Alessio, Adam M., McDougald, Wendy A., Doot, Robert K., Kinahan, Paul E.
Publicado no J Nucl Med (2011)

PET/CT Assessment of Response to Therapy: Tumor Change Measurement, Truth Data, and Error

Por Kinahan, Paul E, Doot, Robert K, Wanner-Roybal, Michelle, Bidaut, Luc M, Armato, Samuel G, Meyer, Charles R, McLennan, Geoffrey
Publicado em 2009

Positron Emission Tomography Imaging of Poly–(Adenosine Diphosphate–Ribose) Polymerase 1 Expression in Breast Cancer: A Nonrandomized Clinical Trial

Por McDonald, Elizabeth S., Doot, Robert K., Pantel, Austin R., Farwell, Michael D., Mach, Robert H., Maxwell, Kara N., Mankoff, David A.
Publicado no JAMA Oncol (2020)

Dynamic and Static Approaches to Quantifying (18)F-FDG Uptake for Measuring Cancer Response to Therapy, Including the Effect of Granulocyte CSF

Por Doot, Robert K., Dunnwald, Lisa K., Schubert, Erin K., Muzi, Mark, Peterson, Lanell M., Kinahan, Paul E., Kurland, Brenda F., Mankoff, David A.
Publicado em 2007

Multicenter clinical trials using (18)F-FDG PET to measure early oncology therapy response: Effects of injection-to-acquisition time variability on required sample size

Por Kurland, Brenda F, Muzi, Mark, Peterson, Lanell M, Doot, Robert K, Wangerin, Kristen A, Mankoff, David A, Linden, Hannah M, Kinahan, Paul E
Publicado no J Nucl Med (2015)

Decreased nicotinic receptor availability in smokers with slow rates of nicotine metabolism

Por Dubroff, Jacob G., Doot, Robert K., Falcone, Mary, R, Robert A. Schnoll, Ray, Riju, Tyndale, Rachel F., Brody, Arthur L., Hou, Catherine, Schmitz, Alexander, Lerman, Caryn
Publicado no J Nucl Med (2015)

Evaluation of Cross-Calibrated (68)Ge/(68)Ga Phantoms for Assessing PET/CT Measurement Bias in Oncology Imaging for Single- and Multicenter Trials

Por Byrd, Darrin W., Doot, Robert K., Allberg, Keith C., MacDonald, Lawrence R., McDougald, Wendy A., Elston, Brian F., Linden, Hannah M., Kinahan, Paul E.
Publicado no Tomography (2016)

METABOLIC AND VASCULAR FEATURES OF DYNAMIC CONTRAST ENHANCED BREAST MRI AND (15)O-WATER PET BLOOD FLOW IN BREAST CANCER

Por Eby, Peter R., Partridge, Savannah C., White, Steven W., Doot, Robert K., Dunnwald, Lisa K., Schubert, Erin K., Kurland, Brenda F., Lehman, Constance D., Mankoff, David A.
Publicado em 2008

(18)F-Fluciclovine PET to distinguish treatment-related effects from disease progression in recurrent glioblastoma: PET fusion with MRI guides neurosurgical sampling

Por Henderson, Fraser, Brem, Steven, O’Rourke, Donald M, Nasrallah, MacLean, Buch, Vivek P, Young, Anthony J, Doot, Robert K, Pantel, Austin, Desai, Arati, Bagley, Stephen J, Nabavizadeh, S Ali
Publicado no Neurooncol Pract (2020)